Magenta Therapeutics, Inc. (MGTA): Price and Financial Metrics

Magenta Therapeutics, Inc. (MGTA)

Today's Latest Price: $13.77 USD

0.17 (-1.22%)

Updated Jan 23 5:20pm

Add MGTA to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MGTA Daily Price Range
MGTA 52-Week Price Range

MGTA Stock Price Chart More Charts

MGTA Price/Volume Stats

Current price $13.77 52-week high $21.00
Prev. close $13.94 52-week low $6.31
Day low $13.14 Volume 71,308
Day high $14.01 Avg. volume 105,600
50-day MA $13.43 Dividend yield N/A
200-day MA $12.99 Market Cap 536.89M

Magenta Therapeutics, Inc. (MGTA) Company Bio

Magenta Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing medicines to bring the curative power of bone marrow transplant to patients. It is developing C100, C200, and C300 targeted antibody-drug conjugates for transplant conditioning; MGTA-145, a stem cell mobilization product candidate to control stem cell mobilization; MGTA-456, an allogeneic stem cell therapy to control stem cell growth; E478, a small molecule aryl hydrocarbon receptor antagonist for the expansion of gene-modified stem cells; and G100, an ADC program to prevent acute graft and host diseases. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. The company was founded in 2015 and is based in Cambridge, Massachusetts.

MGTA Latest News Stream

Event/Time News Detail
Loading, please wait...

MGTA Latest Social Stream

Loading social stream, please wait...

View Full MGTA Social Stream

MGTA Price Returns

1-mo -12.79%
3-mo 49.84%
6-mo 4.56%
1-year 97.00%
3-year N/A
5-year N/A
YTD -9.17%
2019 165.96%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4889 seconds.